TrialKey

TrialKey is a global leader in AI-driven clinical trial optimisation, dedicated to transforming how trials are designed, managed, and executed. Using cutting-edge predictive analytics, machine learning, and biostatistical validation, TrialKey delivers precise, data-backed solutions to improve the efficiency and success of clinical research. Our platform leverages a robust dataset of over 468,000 trials, covering more than 114,000 conditions and insights from 2.69 billion patients. By analysing 1,300 variables for each trial, we provide detailed recommendations on trial design, including inclusion and exclusion criteria, optimal site locations, patient enrolment, and study arm structures. These insights help researchers enhance recruitment, minimise dropouts, and optimise trial success rates. With a market-leading 92% accuracy in predicting trial phase completion, TrialKey offers unparalleled reliability. Each trial design is simulated up to 100,000 times to forecast outcomes, patient dropout rates, and potential risks. This approach reduces uncertainty, conserves resources, and accelerates the path to innovation. TrialKey supports contract research organisations, pharmaceutical companies, and biotech innovators with comprehensive reports that include success probability, competitor benchmarking, and feature impact analysis. Our solutions are tailored to meet the needs of modern clinical trials, ensuring scalability, regulatory alignment, and precision. Through AI-driven insights, TrialKey empowers researchers to achieve faster, more efficient, and patient-centred trials. For more information, visit TrialKey.ai or contact us at support@trialkey.ai. Book a demo: https://appt.link/meet-with-trial-key-team Sales enquiries: minhthu.caoxuan@trialkeyl.ai Marketing enquiries: bernice@triakey.ai